Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Meyer

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Thrombosis Research|October 27, 2006
Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome studyFlorence Parent, Sophie Maître, Guy Meyer, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 17, 2013
Diuretics in normotensive patients with acute pulmonary embolism and right ventricular dilatationJulien Ternacle, Romain Gallet, Armand Mekontso-Dessap, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysisCéline Chapelle, Philippe Girard, Luis Jara-Palomares, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survivalHelene Doubre, Isabelle Monnet, Reza Azarian, et al.
Respirology (Carlton, Vic.)|November 26, 2016
Pathophysiology of dyspnoea in acute pulmonary embolism: A cross-sectional evaluationOlivier Sanchez, Aurore Caumont-Prim, Elisabeth Riant, et al.
Journal of the American College of Cardiology|January 22, 2016
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE RegistryDavid Jiménez, Javier de Miguel-Díez, Ricardo Guijarro, et al.
Thrombosis Research|April 9, 2013
The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolismFranck Verschuren, Mathieu Bonnet, Marie-Odile Benoit, et al.
European Heart Journal|October 7, 2005
Validation of a model to predict adverse outcomes in patients with pulmonary embolismDrahomir Aujesky, Pierre-Marie Roy, Cédric Petit Le Manach, et al.
Circulation|February 21, 2007
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyMarianne Canonico, Emmanuel Oger, Geneviève Plu-Bureau, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Thrombosis Research|October 27, 2006
Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome studyFlorence Parent, Sophie Maître, Guy Meyer, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 17, 2013
Diuretics in normotensive patients with acute pulmonary embolism and right ventricular dilatationJulien Ternacle, Romain Gallet, Armand Mekontso-Dessap, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysisCéline Chapelle, Philippe Girard, Luis Jara-Palomares, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survivalHelene Doubre, Isabelle Monnet, Reza Azarian, et al.
Respirology (Carlton, Vic.)|November 26, 2016
Pathophysiology of dyspnoea in acute pulmonary embolism: A cross-sectional evaluationOlivier Sanchez, Aurore Caumont-Prim, Elisabeth Riant, et al.
Journal of the American College of Cardiology|January 22, 2016
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE RegistryDavid Jiménez, Javier de Miguel-Díez, Ricardo Guijarro, et al.
Thrombosis Research|April 9, 2013
The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolismFranck Verschuren, Mathieu Bonnet, Marie-Odile Benoit, et al.
European Heart Journal|October 7, 2005
Validation of a model to predict adverse outcomes in patients with pulmonary embolismDrahomir Aujesky, Pierre-Marie Roy, Cédric Petit Le Manach, et al.
Circulation|February 21, 2007
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyMarianne Canonico, Emmanuel Oger, Geneviève Plu-Bureau, et al.
Pageof 14